Henderson Molly's Form 4 filing
Phathom Pharmaceuticals, Inc. (PHAT) · filed Jan 23, 2025
- Accession no.
- 0000950170-25-008357
- Filed
- Jan 23, 2025
- Trade date
- Jan 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $43.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson MollyCIK 0001363812 | Officer (CFO and CBO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Common Stock | SSaleDisposed | −6,583 | $6.59 | −$43,381.97 | 93,546 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.